NYSE:STE - Steris Stock Price, Price Target & More

Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

Steris announced a quarterly dividend on Friday, May 11th. Stockholders of record on Friday, June 8th will be given a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Thursday, June 7th. View Steris' Dividend History.

Steris PLC (NYSE:STE) released its earnings results on Wednesday, May, 9th. The medical equipment provider reported $1.24 EPS for the quarter, beating analysts' consensus estimates of $1.22 by $0.02. The medical equipment provider earned $716 million during the quarter, compared to analyst estimates of $703.37 million. Steris had a return on equity of 11.55% and a net margin of 11.10%. The company's revenue was up 5.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.11 EPS. View Steris' Earnings History.

Steris is scheduled to release their next quarterly earnings announcement on Tuesday, August, 14th 2018. View Earnings Estimates for Steris.

Steris issued an update on its FY19 earnings guidance on Wednesday, May, 9th. The company provided EPS guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.69.

4 equities research analysts have issued 1-year price targets for Steris' shares. Their predictions range from $16.00 to $103.00. On average, they anticipate Steris' share price to reach $80.25 in the next twelve months. This suggests that the stock has a possible downside of 28.8%. View Analyst Ratings for Steris.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Steris in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Steris include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Inogen (INGN), MSA Safety (MSA), Halyard Health (HYH), Wright Medical Group (WMGI), CONSORT Med PLC/S (CSRMY), Invacare (IVC), Sientra (SIEN), RTI Surgical (RTIX) and Lakeland Industries (LAKE).

News articles about STE stock have been trending somewhat positive this week, according to Accern Sentiment. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Steris earned a news sentiment score of 0.15 on Accern's scale. They also gave news headlines about the medical equipment provider an impact score of 48.83 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.

Steris' stock is owned by a number of of retail and institutional investors. Top institutional investors include Fisher Asset Management LLC (1.70%), Bank of Montreal Can (0.41%), Channing Capital Management LLC (0.16%), Retirement Systems of Alabama (0.13%), West Coast Financial LLC (0.10%) and Sit Investment Associates Inc. (0.03%). Company insiders that own Steris stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.

STE stock was sold by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Channing Capital Management LLC, Fisher Asset Management LLC, Municipal Employees Retirement System of Michigan, Sit Investment Associates Inc., West Coast Financial LLC, Benjamin F. Edwards & Company Inc. and Private Trust Co. NA. Company insiders that have sold Steris company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Insider Buying and Selling for Steris.

STE stock was acquired by a variety of institutional investors in the last quarter, including Addenda Capital Inc., Bank of Montreal Can, Clinton Group Inc., State of Alaska Department of Revenue, Empirical Finance LLC, Addenda Capital Inc. and Louisiana State Employees Retirement System. View Insider Buying and Selling for Steris.

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of STE stock can currently be purchased for approximately $112.6650.

Steris has a market capitalization of $9.47 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. Steris employs 12,000 workers across the globe.

Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]